Saturday 24 September 2011

Dime Time Extended Release


Generic Name: brompheniramine/phenylephrine/phenylpropanolamine (brome fen IR a meen/fen ill EFF rin/fen ill proe pa NOLE a meen)

Brand Names: Dime Time Extended Release


What is Dime Time Extended Release (brompheniramine/phenylephrine/phenylpropanolamine)?

Brompheniramine is an antihistamine. It works against the naturally occurring chemical histamine in your body. Brompheniramine prevents sneezing; itchy, watery eyes and nose; and other symptoms of allergies and hay fever.


Phenylephrine and phenylpropanolamine are decongestants. They constrict (shrink) blood vessels (veins and arteries). This reduces the blood flow to certain areas and allows nasal passages to open up.


Brompheniramine/phenylephrine/phenylpropanolamine is used to treat nasal congestion and sinusitis (inflammation of the sinuses) associated with allergies, hay fever, and the common cold.


Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.


Brompheniramine/phenylephrine/phenylpropanolamine may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about Dime Time Extended Release (brompheniramine/phenylephrine/phenylpropanolamine)?


Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.


Use caution when driving, operating machinery, or performing other hazardous activities. Brompheniramine/phenylephrine/phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking brompheniramine/phenylephrine/phenylpropanolamine.

Do not take more of this medication than is recommended. If your symptoms do not improve, or if they worsen, talk to your doctor.


Who should not take Dime Time Extended Release (brompheniramine/phenylephrine/phenylpropanolamine)?


Do not take brompheniramine/phenylephrine/phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Before taking this medication, tell your doctor if you have


  • kidney disease,

  • liver disease,


  • diabetes,




  • glaucoma,




  • any type of heart disease or high blood pressure,




  • thyroid disease,




  • emphysema or chronic bronchitis, or




  • difficulty urinating or an enlarged prostate.



You may not be able to take brompheniramine/phenylephrine/phenylpropanolamine, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.


Brompheniramine/phenylephrine/phenylpropanolamine is in the FDA pregnancy category B. This means that it is unlikely to harm an unborn baby. Do not take this medication without first talking to your doctor if you are pregnant. This medication passes into breast milk and may harm a nursing baby. Do not take this medication without first talking to your doctor if you are breast-feeding a baby. If you are over 65 years of age, you may be more likely to experience side effects from brompheniramine/phenylephrine/phenylpropanolamine. You may require a lower dose of this medication. Read the package label for directions or consult your doctor or pharmacist before treating a child with this medication. Children are more susceptible than adults to the effects of medicines and may have unusual reactions.

How should I take brompheniramine/phenylephrine/ phenylpropanolamine?


Take brompheniramine/phenylephrine/phenylpropanolamine exactly as directed. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.


Take each dose with a full glass of water. Do not crush, chew, or break the long-acting or sustained-release forms of this medication. Swallow them whole. If you are unsure about the formulation of your medicine, ask your pharmacist for help.

If you cannot swallow the tablets or capsules, look for a liquid form of the medication.


Do not take more of this medication than is recommended. An overdose of this medication can cause serious harm.

Do not take brompheniramine/phenylephrine/phenylpropanolamine for longer than 7 days in a row. If your symptoms do not improve, if they get worse, or if you have a fever, talk to your doctor.


Store brompheniramine/phenylephrine/phenylpropanolamine at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of this medication.


What happens if I overdose?


Seek emergency medical attention.

Symptoms of a brompheniramine/phenylephrine/phenylpropanolamine overdose include a dry mouth, large pupils, flushing, nausea, and vomiting.


What should I avoid while taking Dime Time Extended Release (brompheniramine/phenylephrine/phenylpropanolamine)?


Use caution when driving, operating machinery, or performing other hazardous activities. Brompheniramine/phenylephrine/phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking brompheniramine/phenylephrine/phenylpropanolamine.

Brompheniramine/phenylephrine/phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine/phenylephrine/phenylpropanolamine is taken with any of these medications.


Dime Time Extended Release (brompheniramine/phenylephrine/phenylpropanolamine) side effects


Serious side effects are unlikely to occur. Stop taking brompheniramine/phenylephrine/phenylpropanolamine and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).

Other, less serious side effects may be more likely to occur. Continue to take brompheniramine/phenylephrine/phenylpropanolamine and talk to your doctor or try another similar medication if you experience



  • dryness of the eyes, nose, and mouth;




  • drowsiness or dizziness;




  • blurred vision;




  • difficulty urinating; or




  • excitation in children.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.


What other drugs will affect Dime Time Extended Release (brompheniramine/phenylephrine/phenylpropanolamine)?


Do not take brompheniramine/phenylephrine/phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Do not take other over-the-counter cough, cold, allergy, diet, or sleep aids while taking brompheniramine/phenylephrine/phenylpropanolamine without first talking to your doctor or pharmacist. Other medications may also contain brompheniramine, phenylephrine, phenylpropanolamine, or other similar drugs. You may accidentally take too much of these medicines.


Brompheniramine/phenylephrine/phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine/phenylephrine/phenylpropanolamine is taken with any of these medications.


Drugs other than those listed here may also interact with brompheniramine/phenylephrine/phenylpropanolamine. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.



More Dime Time Extended Release resources


  • Dime Time Extended Release Drug Interactions
  • 0 Reviews for Dime Time Extended Release - Add your own review/rating


Compare Dime Time Extended Release with other medications


  • Cold Symptoms


Where can I get more information?


  • Your pharmacist has additional information about brompheniramine/phenylephrine/ phenylpropanolamine written for health professionals that you may read.

What does my medication look like?


Brompheniramine/phenylephrine/phenylpropanolamine is available with a prescription under the brand names Bromophen T.D. and Tamine S.R. These medications contain 12 mg of brompheniramine, 15 mg of phenylephrine, and 15 mg of phenylpropanolamine. Other brand or generic formulations may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.



Friday 23 September 2011

Dikmed




Dikmed may be available in the countries listed below.


Ingredient matches for Dikmed



Diclofenac

Diclofenac is reported as an ingredient of Dikmed in the following countries:


  • Poland

International Drug Name Search

Monday 19 September 2011

Arcapta


Arcapta is a brand name of indacaterol, approved by the FDA in the following formulation(s):


ARCAPTA NEOHALER (indacaterol maleate - powder; inhalation)



  • Manufacturer: NOVARTIS

    Approval date: July 1, 2011

    Strength(s): EQ 75MCG BASE [RLD]

Has a generic version of Arcapta been approved?


No. There is currently no therapeutically equivalent version of Arcapta available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Arcapta. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Beta2-adrenoceptor agonists
    Patent 6,878,721
    Issued: April 12, 2005
    Inventor(s): Cuenoud; Bernard & Bruce; Ian & Fairhurst; Robin Alec & Beattie; David
    Assignee(s): Novartis AG
    Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Patent expiration dates:

    • October 10, 2020
      ✓ 
      Patent use: THE LONG TERM, ONCE-DAILY MAINTENANCE BROCHODILATOR TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND/OR EMPHYSEMA
      ✓ 
      Drug substance
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • July 1, 2016 - NEW CHEMICAL ENTITY

See also...

  • Arcapta Consumer Information (Drugs.com)
  • Arcapta Neohaler Consumer Information (Wolters Kluwer)
  • Arcapta Neohaler inhalation Consumer Information (Cerner Multum)
  • Arcapta Neohaler Advanced Consumer Information (Micromedex)
  • Indacaterol Consumer Information (Wolters Kluwer)
  • Indacaterol inhalation Consumer Information (Cerner Multum)
  • Indacaterol Inhalation Advanced Consumer Information (Micromedex)

Monday 12 September 2011

Lovastatina Teva




Lovastatina Teva may be available in the countries listed below.


Ingredient matches for Lovastatina Teva



Lovastatin

Lovastatin is reported as an ingredient of Lovastatina Teva in the following countries:


  • Spain

International Drug Name Search

Sunday 11 September 2011

Nitrofurantoine CF




Nitrofurantoine CF may be available in the countries listed below.


Ingredient matches for Nitrofurantoine CF



Nitrofurantoin

Nitrofurantoin is reported as an ingredient of Nitrofurantoine CF in the following countries:


  • Netherlands

International Drug Name Search

Thursday 8 September 2011

Glimepirid Winthrop




Glimepirid Winthrop may be available in the countries listed below.


Ingredient matches for Glimepirid Winthrop



Glimepiride

Glimepiride is reported as an ingredient of Glimepirid Winthrop in the following countries:


  • Denmark

  • Finland

  • Germany

  • Lithuania

  • Slovenia

International Drug Name Search

Wednesday 7 September 2011

Vetamox




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vetamox



Acetazolamide

Acetazolamide sodium salt (a derivative of Acetazolamide) is reported as an ingredient of Vetamox in the following countries:


  • United States

International Drug Name Search

Flutamid-CT




Flutamid-CT may be available in the countries listed below.


Ingredient matches for Flutamid-CT



Flutamide

Flutamide is reported as an ingredient of Flutamid-CT in the following countries:


  • Germany

International Drug Name Search

Monday 5 September 2011

Laimolin




Laimolin may be available in the countries listed below.


Ingredient matches for Laimolin



Dequalinium Chloride

Dequalinium Chloride is reported as an ingredient of Laimolin in the following countries:


  • Venezuela

International Drug Name Search